Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dosing for postoperative visceral pain after laparoscopic surgery
ChiCTR2300075421Phase 4Recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and referred pain (3 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoint: Visceral pain VAS score. Started Aug 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painreferred pain
Beyond the preview
Go deeper on ChiCTR2300075421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075421.